Ho Tung Chemical Corp. (TPE:1714)
Taiwan · Delayed Price · Currency is TWD 9.23
+0.06 (0.65%)
Mar 13, 2026, 1:30 PM CST
Ho Tung Chemical Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 24,021 | 20,619 | 20,292 | 22,644 | 20,211 | |
Revenue Growth (YoY) | 16.50% | 1.61% | -10.39% | 12.04% | -21.81% |
Cost of Revenue | 21,516 | 18,700 | 18,376 | 20,583 | 17,123 |
Gross Profit | 2,506 | 1,920 | 1,916 | 2,061 | 3,088 |
Selling, General & Admin | 1,170 | 1,170 | 1,077 | 1,175 | 1,240 |
Research & Development | 78.47 | 73.83 | 70.19 | 89.63 | 75.24 |
Other Operating Expenses | - | - | - | -0.25 | -1.68 |
Operating Expenses | 1,249 | 1,010 | 1,146 | 1,265 | 1,306 |
Operating Income | 1,257 | 909.74 | 770.01 | 796.93 | 1,782 |
Interest Expense | -77.94 | -79.95 | -89.82 | -91.89 | -115.99 |
Interest & Investment Income | 171.94 | 230.21 | 312.2 | 144.12 | 145.01 |
Earnings From Equity Investments | 8.25 | 13.31 | 22.66 | 23.06 | 10.75 |
Currency Exchange Gain (Loss) | - | 55.02 | 10.39 | 5.93 | -11.28 |
Other Non Operating Income (Expenses) | 255.73 | -86.78 | 45.5 | 25.92 | 304.73 |
EBT Excluding Unusual Items | 1,615 | 1,042 | 1,071 | 904.07 | 2,115 |
Gain (Loss) on Sale of Investments | - | -0.03 | 0.01 | -0.37 | 3.79 |
Gain (Loss) on Sale of Assets | - | 37.36 | -12.43 | -3.82 | -128.42 |
Asset Writedown | - | -18.53 | -7.75 | 0.04 | -0.3 |
Other Unusual Items | - | - | - | - | 0.31 |
Pretax Income | 1,615 | 1,060 | 1,051 | 899.93 | 1,991 |
Income Tax Expense | 415.45 | 343.28 | 179.5 | 257.36 | 531.33 |
Earnings From Continuing Operations | 1,200 | 717.07 | 871.28 | 642.57 | 1,460 |
Minority Interest in Earnings | -709.88 | -301.6 | -272.22 | -272.34 | -736.8 |
Net Income | 490.12 | 415.46 | 599.06 | 370.23 | 722.75 |
Net Income to Common | 490.12 | 415.46 | 599.06 | 370.23 | 722.75 |
Net Income Growth | 17.97% | -30.65% | 61.81% | -48.77% | -57.14% |
Shares Outstanding (Basic) | 980 | 1,007 | 1,007 | 1,005 | 1,003 |
Shares Outstanding (Diluted) | 980 | 1,008 | 1,008 | 1,005 | 1,004 |
Shares Change (YoY) | -2.77% | 0.01% | 0.27% | 0.12% | -0.08% |
EPS (Basic) | 0.50 | 0.41 | 0.60 | 0.37 | 0.72 |
EPS (Diluted) | 0.50 | 0.41 | 0.59 | 0.37 | 0.72 |
EPS Growth | 21.95% | -30.51% | 60.10% | -48.82% | -57.14% |
Free Cash Flow | 840.24 | 1,157 | 1,236 | -236.9 | 1,737 |
Free Cash Flow Per Share | 0.86 | 1.15 | 1.23 | -0.24 | 1.73 |
Dividend Per Share | - | 0.205 | 0.300 | 0.100 | 0.420 |
Dividend Growth | - | -31.65% | 200.00% | -76.19% | -40.00% |
Gross Margin | 10.43% | 9.31% | 9.44% | 9.10% | 15.28% |
Operating Margin | 5.24% | 4.41% | 3.79% | 3.52% | 8.82% |
Profit Margin | 2.04% | 2.02% | 2.95% | 1.64% | 3.58% |
Free Cash Flow Margin | 3.50% | 5.61% | 6.09% | -1.05% | 8.59% |
EBITDA | 1,780 | 1,431 | 1,275 | 1,259 | 2,216 |
EBITDA Margin | 7.41% | 6.94% | 6.28% | 5.56% | 10.96% |
D&A For EBITDA | 522.65 | 521.1 | 504.5 | 462.47 | 433.64 |
EBIT | 1,257 | 909.74 | 770.01 | 796.93 | 1,782 |
EBIT Margin | 5.24% | 4.41% | 3.79% | 3.52% | 8.82% |
Effective Tax Rate | 25.72% | 32.37% | 17.08% | 28.60% | 26.69% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.